Login / Signup

The peripheral CD4 + T cells predict efficacy in non-small cell lung cancer (NSCLC) patients with the anti-PD-1 treatment.

Weixia ZhuangMoufeng WangLi JiangZudong SuShenglu Lin
Published in: Translational cancer research (2024)
T cells at baseline could predict anti-PD-1 efficacy in NSCLC patients.
Keyphrases